The respondents for this collection
are institutions or organizations operating IRBs designated by an
institution under an assurance of compliance approved for
federalwide use by OHRP under 45 CFR 46.103(a) and that review
human subjects research conducted or supported by HHS, or, in the
case of FDA's regulation, each IRB in the United States that
reviews clinical investigations regulated by FDA under sections
505(i) or 520(g) of the Federal Food, Drug and Cosmetic Act; and
each IRB in the United States that reviews clinical investigations
that are intended to support applications for research or marketing
permits for FDA-regulated products.
In summary, the inventory of
registered IRBs in 2012 (6,100) has reduced in 2015 by 200 IRBs (to
5,900) and our projection for how many new IRBs will register has
reduced by 400 (from 900 in 2012 to 500 in 2015).
$400,000
No
No
No
No
No
Uncollected
Sherrette Funn-Coleman
2026905683
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.